Antifungal Resistance And Susceptibility

5 researchers across 2 institutions

5 Researchers
2 Institutions
0 Grant PIs
4 High Impact

Research in antifungal resistance and susceptibility investigates the mechanisms by which fungal pathogens evade or respond to antifungal treatments. Studies explore the genetic and biochemical pathways involved in drug resistance, analyze fungal susceptibility profiles to various antifungal agents, and examine the impact of environmental factors on these processes. This area encompasses work on both human and plant fungal pathogens, utilizing molecular biology, genomics, and biochemical assays to understand drug targets and resistance mechanisms.

This research holds significant relevance for Arkansas. Fungal diseases pose threats to both human health and agriculture, key sectors in the state's economy. Understanding and combating antifungal resistance is critical for effective treatment of infections in vulnerable populations and for protecting crop yields from devastating plant pathogens, such as those affecting rice and poultry industries. Work in this area contributes to public health initiatives and supports the state's agricultural productivity and economic stability.

This research area draws upon expertise in microbial infections, plant pathology, pharmacology, and ecology. Collaboration occurs across multiple institutions within Arkansas, fostering a broad approach to understanding and addressing the challenges of antifungal resistance and susceptibility.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
William J. Steinbach UAMS 68 26,515 High Impact
M. W. Shaw University of Arkansas 45 6,874 High Impact
Robert W. Bradsher UAMS 36 8,875 High Impact
Burton H. Bluhm University of Arkansas 24 4,169 High Impact
Jacob M. Keck UAMS 5 73

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
8,066 works in 2025
+2.6% CAGR 2018–2025
Leadership concentration
3.6% held by global top 5 institutions
Fragmented HHI 13
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas at San Antonio Health Science Center 1,129
  2. 2 The University of Texas MD Anderson Cancer Center 1,023
  3. 3 Duke Medical Center 977
  4. 4 Centers for Disease Control and Prevention 949
  5. 5 Johns Hopkins University 896
Browse All 5 Researchers in Directory